zuberitamab Solution for injection 100 mg - 10 ml
Dossier type
CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
China
Manufacturer #38152
A pharmaceutical manufacturer focused on discovering, developing, manufacturing and commercializing innovative therapeutic medicines, particularly antibody-based and biologic treatments for immune-mediated diseases and oncology. The company operates integrated R&D and production capabilities to support the development and supply of advanced pharmaceutical products designed to address serious disease areas, with a full-cycle approach from discovery through commercialization.
Manufacturer usually replies in 45 days